Paul J. Diaz, President and CEO at MYRIAD GENETICS INC (MYGN), sold 285,688 shares at $25.21 ($7.2M) on 2024-05-14, disclosed to the SEC on 2024-05-15.
Open-market sale of $7.2M MYGN by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.13 | 57,844 | $1.5M | 20.2% |
| 2 | $25.13 | 57,844 | $1.5M | 20.2% |
| 3 | $25.21 | 95,000 | $2.4M | 33.3% |
| 4 | $25.07 | 75,000 | $1.9M | 26.2% |
| Total | $25.14 avg | 285,688 | $7.2M | 100% |
| Filing → |
| DVA | SELL | 2020-05-19 | $923K | — | Filing → |
| KND | BUY | 2015-11-12 | $627K | — | Filing → |
| KND | SELL | 2014-03-07 | $2.5M | — | Filing → |